Abbott Laboratories (ABT)

82.22
NYSE : Health Technology
Prev Close 82.29
Day Low/High 82.02 / 82.86
52 Wk Low/High 60.32 / 82.33
Avg Volume 5.28M
Exchange NYSE
Shares Outstanding 1.76B
Market Cap 145.17B
EPS 1.30
P/E Ratio 55.98
Div & Yield 1.28 (1.46%)

Updating Past Recommendations: ADM, GLW, MET, STJ, GLW

Recent company-related activities are worth noting and could merit action.

A Closer Look at Abbott Labs

A Closer Look at Abbott Labs

Nicole Urken, research associate of Jim Cramer, likes Abbott Labs and says it's not just an Obama trade.

Still Some Standouts

Some sectors -- albeit, boring ones -- are acting well.

Abbott Laboratories upgraded at Wells

Watch Out for the Tightrope

It's been a thoroughly boring, commonsense rally.

Britol-Myers Squibb Catches a Ride

Abbott gets some good news on its Hep C drug, which has buoyed Bristol-Myers. Some positive Hep C data out of Abbott Labs (ABT) (hat tip Steph Link!) is buyoing Bristol-Myers Squibb (BMY) this morning.

The 5 Dumbest Things on Wall Street: October 5

The 5 Dumbest Things on Wall Street: October 5

Here is this week's roundup of the dumbest actions on Wall Street.

The Next Big Thing in Biotech: Hepatitis Drugs

The Next Big Thing in Biotech: Hepatitis Drugs

Senior columnist Adam Feuerstein says hepatitis drugs are the next big thing to watch in biotech.

Abbott numbers raised at Jefferies

Abbott Labs, UPS Ready to Deliver

Abbott Labs, UPS Ready to Deliver

In this episode of Buy This, Sell That!, Robert Zagunis, portfolio manager for the Jensen Quality Growth fund, names his favorite stocks including Abbott Labs, UPS and Praxair.

3 Stocks I Saw On TV, July 30

3 Stocks I Saw On TV, July 30

Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Amgen, Gilead, and Celgene.

Trading Abbott for Bristol Myers

Trading Abbott for Bristol Myers

Stephanie Link, director of research at TheStreet, eliminated her position in Abbott to build a position in Bristol Meyers.

Thank You, and Looking Ahead

Here's some of what we can look forward to on Wednesday. It's always an honor to fill in for Doug! Thanks for spending the day with me. Tomorrow, Fed Chairman Ben Bernanke appears before the House. His statement will likely be a replay of today's, b...

3 Stocks I Saw on TV, June 4

3 Stocks I Saw on TV, June 4

Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Abbott Laboratories, ConocoPhillips, and Facebook.

Big Pharma Convalesces

Big Pharma Convalesces

Traders and investors rediscover the virtues of pharmaceutical companies.

Split Shift

Not everything deserves to live under one roof.

Abbott Laboratories upgraded at Deutsche

The Dividend-Stock Comeback

Latch on to this rising trend with these names, which achieved top marks with my stock strategies.

Forming a Sideways Zone

Forming a Sideways Zone

As the Dow hovers around 13,000, it appears to be forming a trading range.

Fitz Bits: Scoop Up Intel Shares

Fitz Bits: Scoop Up Intel Shares

Intel is attracting institutional buyers, and it always pays to follow that crowd.

Scooped Up Some Pre-Earnings Action

Scooped Up Some Pre-Earnings Action

I've finally picked up some Abbott Labs stock, which has been slowly breaking out of a base.

Top Dividend Stocks For 2012: Intel, Abbott Labs

Top Dividend Stocks For 2012: Intel, Abbott Labs

Oliver Pursche, portfolio manager for the GMG Defensive Beta fund, names his favorite high dividend paying stocks including McDonald's, Intel and Abbott Labs.

Diary of a Dividend Diva: LTD, FTR

Lessons learned in 2011, and what to look for in 2012.

Abbott's Chart Looks Buyable

Abbott's Chart Looks Buyable

The stock offers nice price action as well as a healthy yield.

Mead Johnson Has a Winning Formula

The pediatric nutrition company leads the industry, and demand remains firm despite economic slowdowns.